Help us improve Portfolio Grader.

Help us improve Portfolio Grader.

Blue Chip Growth

Stock Report: () Report Updated: Sep 16, 2017 | Print This Page

Get more stock ratings by Louis Navellier


Rating: Volatility:
Total Grade: Industry:

Stock Analysis

Rating: Monthly View

September October November December January February March April May June July August

Rating: Weekly View

This Week: down no change
Last Week: same no change
Two Weeks Ago: up no change
service keys

© quotemedia

Company Profile

Vascular Solutions, Inc., a medical device company, provides clinical solutions for treating coronary and peripheral vascular disease worldwide. The company’s primary products include GuideLiner guide extension catheter device for use in complex interventions; Pronto extraction catheters for treating acute myocardial infarction; vein catheter reprocessing service for the radiofrequency vein ablation catheter; and micro-introducer kits that are used to gain percutaneous access to the vasculature to perform minimally invasive procedures. Its products also comprise hemostatic patches consisting of blood clotting products, such as the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding; radial access products, including the Accumed wrist positioning splints and Vasc Band inflatable compression bands; Langston catheter used for the measurement of intravascular pressure gradients, primarily to diagnose aortic valve stenosis; and D-Stat Flowable hemostat that is used to control active bleeding. The company sells its products through direct sales force and distributor to interventional cardiologists, interventional radiologists, electrophysiologists, and vein specialists. Vascular Solutions, Inc. was founded in 1996 and is headquartered in Minneapolis, Minnesota.